NXTC

NextCure, Inc. NXTC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NXTC ASMB CTMX TECX TIL
6M 90.54 % 191.96 % 530.99 % -0.87 % 27.94 %
YTD -32.56 % 54.58 % 216.98 % -64.94 % -11.05 %
1Y -60.42 % 55.85 % 208.26 % -52.53 % -55.87 %
3Y -80.42 % 32.29 % 136.62 % 122.50 % -79.10 %
5Y -95.19 % -85.96 % -51.30 % -91.58 % -96.36 %
10Y -97.22 % -76.82 % -72.75 % -95.72 % -96.36 %
From the beginning -97.22 % -92.99 % -73.95 % -95.72 % -96.36 %

Dividend